BTIG Downgrades DexCom (DXCM) to Neutral

September 14, 2016 7:06 AM EDT
Get Alerts DXCM Hot Sheet
Price: $84.16 --0%

Rating Summary:
    16 Buy, 9 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 8 | New: 1
Trade DXCM Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

BTIG downgraded DexCom (NASDAQ: DXCM) from Buy to Neutral and removed its price target. Analyst Sean Lavin thinks shares are fairly valued given the stock's run.

"While we do not think shares are overvalued and could argue for a bit more upside as revenue should continue to exceed guidance in our opinion, we do feel a lot of good news is priced in, and given the historical volatility we would like more significant upside than we see at this time to maintain our Buy rating. One additional issue is investors are starting to focus on margins and profitability," said Lavin.

For an analyst ratings summary and ratings history on DexCom click here. For more ratings news on DexCom click here.

Shares of DexCom closed at $91.88 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Downgrades

Related Entities


Add Your Comment